Hepatocarcinoma: from pathogenic mechanisms to target therapy
Hepatocellular carcinoma (HCC) is among the most prevalent and lethal cancers worldwide. It is currently estimated that there are 14,000–18,000 new cases of hepatocellular carcinoma in the United States each year. It is often difficult to identify individuals at risk for HCC. The main associated dis...
| Published in: | Oncology Reviews |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2011-12-01
|
| Subjects: | |
| Online Access: | http://www.oncologyreviews.org/index.php/or/article/view/129 |
